John L. Neumeyer
Affiliations: | Northeastern University, Boston, MA, United States |
Google:
"John Neumeyer"Mean distance: 24.26 (cluster 15)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Xu Y, Sromek AW, Neumeyer JL. (2019) Identification of fluorinated (R)-(-)-aporphine derivatives as potent and selective ligands at serotonin 5-HT receptor. Bioorganic & Medicinal Chemistry Letters. 29: 230-233 |
| Subburaju S, Sromek AW, Seeman P, et al. (2018) New Dopamine D2 Receptor Agonist, [H]MCL-536, for Detecting Dopamine D2high Receptors in Vivo. Acs Chemical Neuroscience |
| Lincoln L, Fisher R, Jackson MJ, et al. (2016) Oral r-(-)-11-o-valeryl-n-n-propylnoraporphine reverses motor deficits in mptp-treated marmosets. Movement Disorders : Official Journal of the Movement Disorder Society |
| Sromek AW, Zhang S, Akurathi V, et al. (2014) Convenient synthesis of 18F-radiolabeled R-(-)-N-n-propyl-2-(3-fluoropropanoxy-11-hydroxynoraporphine. Journal of Labelled Compounds & Radiopharmaceuticals. 57: 725-9 |
| Sun JF, Wang YH, Chai JR, et al. (2014) Pharmacological characterization and therapeutic potential for the treatment of opioid abuse with ATPM-ET, an N-ethyl substituted aminothiazolomorphinan with κ agonist and μ agonist/antagonist activity. European Journal of Pharmacology. 740: 455-63 |
| Finnema SJ, Stepanov V, Nakao R, et al. (2014) (18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1164-70 |
| Sromek AW, Provencher BA, Russell S, et al. (2014) Preliminary pharmacological evaluation of enantiomeric morphinans. Acs Chemical Neuroscience. 5: 93-9 |
| Provencher BA, Sromek AW, Li W, et al. (2013) Synthesis and pharmacological evaluation of aminothiazolomorphinans at the mu and kappa opioid receptors. Journal of Medicinal Chemistry. 56: 8872-8 |
| Ye N, Neumeyer JL, Baldessarini RJ, et al. (2013) Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. Chemical Reviews. 113: PR123-78 |
| Neumeyer JL, Zhang B, Zhang T, et al. (2012) Synthesis, binding affinity, and functional in vitro activity of 3-benzylaminomorphinan and 3-benzylaminomorphine ligands at opioid receptors. Journal of Medicinal Chemistry. 55: 3878-90 |